The number of T cells, especially activated CD8+ cytotoxic T cells and Th1 cells, correlates with better survival in some cancers, including invasive colorectal cancer, melanoma, multiple myeloma, and pancreatic cancer [48]. This evidence concerns the gene CD8A and melanoma.